Edit |   |
---|---|
Antigenic Specificity | IL23A, Human (Brazikumab biosimilar) |
Clone | Brazikumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, FCM, IP, IF, Inhib, PK |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL23A Recombinant Antibody (Brazikumab). Brazikumab (INN, development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease. This drug was developed by MedImmune. |
Immunogen | n/a |
Other Names | Anti-IL23A Recombinant Antibody, Research Grade Brazikumab, Anti-Human IL23A Recombinant Antibody(Brazikumab), AMG-139, MEDI2070, Antibody Drug Analogues, Monoclonal Antibody, YR1440, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1610353-18-8 |
Catalog # | YR1440 |
Price | please inquire |
Order / More Info | IL23A, Human (Brazikumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |